Evidence for Receptor-mediated Binding of Glycoproteins, Glycoconjugates, and Lysosomal Glycosidases by Alveolar Macrophages
Overview
Authors
Affiliations
Alveolar macrophages have been shown to bind glycoproteins and synthetic glycoconjugates (neoglycorpoteins) that have mannose, N-acetylglucosamine, or glucose in the exposed, nonreducing position. Galactose-terminal glycoproteins are not bound. Binding of radiolabeled ligands to cells is nearly completely impaired by the presence of an excess of yeast mannan. Binding is temperature sensitive and proceeds optimally at pH 7.0. Prior treatment of the cells with trypsin severely decreases their capacity to bind ligands. An inhibition assay has been developed, using radioiodinated glucose-albumin conjugate, agalacto-orosomucoid, beta-glucuronidase, and RNase B as ligands. Various glycoproteins have been shown to be effective inhibitors of ligand binding including horseradish peroxidase, agalacto-orosomucoid, beta-glucuronidase, ovalbumin, agalacto-fetuin, and RNase B. RNase A and asialo-fetuin are ineffective as antagonists. The results suggest the presence of a cell surface receptor on alveolar macrophages that binds glycoproteins having terminal sugars with the mannose or glucose configuration.
Niu P, Zhao L, Yang J, Ding Y, Xu X, Li S Adv Healthc Mater. 2024; 14(3):e2402976.
PMID: 39618007 PMC: 11773123. DOI: 10.1002/adhm.202402976.
Zhang H, Zhu T, Xu W, Liu B, Wu K, Yin Y Virulence. 2023; 15(1):2283898.
PMID: 37964595 PMC: 11441017. DOI: 10.1080/21505594.2023.2283898.
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies.
Rocamora F, Peralta A, Shin S, Sorrentino J, Wu M, Toth E Biotechnol Adv. 2023; 67:108206.
PMID: 37354999 PMC: 11168894. DOI: 10.1016/j.biotechadv.2023.108206.
Yung H, Zhao X, Glover L, Burrin C, Pang P, Jones C iScience. 2023; 26(1):105911.
PMID: 36660474 PMC: 9843443. DOI: 10.1016/j.isci.2022.105911.
A new horizon of precision medicine: combination of the microbiome and extracellular vesicles.
Yang J, Shin T, Kim J, Jee Y, Kim Y Exp Mol Med. 2022; 54(4):466-482.
PMID: 35459887 PMC: 9028892. DOI: 10.1038/s12276-022-00748-6.